Impact of multiple malignancies on surgical outcomes in patients with 1 cm or smaller non-small cell lung cancer

被引:1
作者
Tsukioka, Takuma [1 ]
Izumi, Nobuhiro [1 ]
Mizuguchi, Shinjiro [1 ]
Kyukwang, Chung [1 ]
Komatsu, Hiroaki [1 ]
Toda, Michihito [1 ]
Hara, Kantaro [1 ]
Miyamoto, Hikaru [1 ]
Nishiyama, Noritoshi [1 ]
机构
[1] Osaka City Univ Hosp, Dept Thorac Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan
关键词
Non-small cell lung cancer; Multiple malignancies; Treatment interval; Prognostic factor; RECURRENCE; CARCINOMA; SURVIVAL; LESS;
D O I
10.1007/s10147-017-1185-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Because most patients with small-sized non-small cell lung cancer (NSCLC) are asymptomatic, their lesions are detected by cancer screenings or routine checkups for other diseases. Incidences of multiple malignancies have been reported to be 27% in patients with stage I-III NSCLC. Some patients have treatment histories for other malignancies, and their small-sized NSCLC was incidentally detected during follow-up. There is no established report regarding the influence of multiple malignancies on small-sized NSCLC prognosis. Therefore, we investigated the correlation between multiple malignancies and surgical outcomes in patients with small-sized NSCLC. In total, 44 patients underwent definitive pulmonary resection for NSCLC of 1 cm or smaller between January 2003 and December 2012. Tumor size was measured by macroscopic findings of the resected specimens, and we then retrospectively investigated their clinical courses. One patient had hemoptysis symptoms, whereas 43 patients were asymptomatic; among them, NSCLC was detected by examinations for other diseases in 31 patients and by cancer screening in 12 patients. In total, 20 patients (45%) had multiple malignancies. The median follow-up period was 68 months. One patient had a recurrence from current NSCLC. No patients died of current NSCLC. The overall 5-year survival rate was 90% for all patients. Patients with multiple malignancies had significantly poorer prognoses compared with those without multiple malignancies (P = 0.016). However, patients with treatment intervals of more than 5 years had prognoses equivalent to those of patients without multiple malignancies (P = 0.829). Only the presence of multiple malignancies was a significantly poor prognostic factor in univariate and multivariate analyses. NSCLC of 1 cm or smaller showed good prognoses. The presence of multiple malignancies was a significantly poor prognostic factor, and short treatment intervals also correlated with poor prognosis.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
  • [41] Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer
    Chan, Ernest G.
    Chan, Patrick G.
    Mazur, Summer N.
    Normolle, Daniel P.
    Luketich, James D.
    Landreneau, Rodney J.
    Schuchert, Matthew J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 161 (05) : 1639 - +
  • [42] Prognostic factors after surgical resection of N1 non-small cell lung cancer
    Mordant, P.
    Pricopi, C.
    Legras, A.
    Arame, A.
    Foucault, C.
    Dujon, A.
    Le Pimpec-Barthes, F.
    Riquet, M.
    EJSO, 2015, 41 (05): : 696 - 701
  • [43] Surgical Staging for Non-Small Cell Lung Cancer
    Gamliel, Ziv
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 20 (04) : 691 - +
  • [44] Characteristics and outcomes of ALK plus non-small cell lung cancer patients in Korea
    Lim, Sung Hee
    Yoh, Kyung Ah
    Lee, Jong Seok
    Ahn, Myung-ju
    Kim, Yu Jung
    Kim, Se Hyun
    Zhang, Jie
    Patel, Dony
    Swallow, Elyse
    Kageleiry, Andrew
    Galebach, Philip
    Lee, Dongyeol
    Stein, Karen
    Degun, Ravi
    Park, Keunchil
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E239 - E245
  • [45] Surgical treatment of stage IV non-small cell lung cancer
    Kawano, Daigo
    Takeo, Sadanori
    Katsura, Masakazu
    Tsukamoto, Shuichi
    Masuyama, Eri
    Nakaji, Yu
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2012, 14 (02) : 167 - 170
  • [46] Non-small cell lung cancer histological subtype has prognostic impact in patients with brain metastases
    Nieder, Carsten
    Grosu, Anca L.
    Marienhagen, Kirsten
    Andratschke, Nicolaus H.
    Geinitz, Hans
    MEDICAL ONCOLOGY, 2012, 29 (04) : 2664 - 2668
  • [47] Role of Surgical Intervention in Unresectable Non-Small Cell Lung Cancer
    Suzuki, Shigeki
    Goto, Taichiro
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 9
  • [48] Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients
    Tomita, Masaki
    Shimizu, Tetsuya
    Hara, Masaki
    Ayabe, Takanori
    Onitsuka, Toshio
    ANTICANCER RESEARCH, 2008, 28 (3B) : 1947 - 1950
  • [49] Prognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients
    Maeda, Ryo
    Yoshida, Junji
    Ishii, Genichiro
    Hishida, Tomoyuki
    Nishimura, Mitsuyo
    Nagai, Kanji
    THORAX, 2010, 65 (12) : 1092 - 1098
  • [50] Use and Impact of Adjuvant Chemotherapy in Patients With Resected Non-Small Cell Lung Cancer
    Williams, Christina D.
    Gajra, Ajeet
    Ganti, Apar K.
    Kelley, Michael J.
    CANCER, 2014, 120 (13) : 1939 - 1947